Gabexate monomethanesulfonate
PubChem Notes:
Gabexate A serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and as a regional anticoagulant for hemodialysis. The drug inhibits the hydrolytic effects of thrombin, plasmin, and kallikrein, but not of chymotrypsin and aprotinin.
Molecular Formula:
C17H27N3O7S
InChI: InChI=1/C16H23N3O4.CH4O3S/c1-2-22-15(21)12-7-9-13(10-8-12)23-14(20)6-4-3-5-11-19-16(17)18;1-5(2,3)4/h7-10H,2-6,11H2,1H3,(H4,17,18,19);1H3,(H,2,3,4)/fC16H24N3O4.CH3O3S/h17H2,18H3;/q+1;-1/b19-16+;
InChIKey: InChIKey=DNTNDFLIKUKKOC-DMUWWESPDZ
SMILES: CCOC(=O)C1=CC=C(C=C1)OC(=O)CCCCCN=C([NH3+])N.CS(=O)(=O)[O-]
Names:
BENZOIC ACID, 4-((6-((AMINOIMINOMETHYL)AMINO)-1-OXOHEXYL)OXY)-, ETHYL ESTER, MON
Ethyl p-(6-guanidinohexanoxyloxy)benzoate methanesulfonate
Ethyl p-(6-guanidinohexanoyloxy) benzoate methanesulfonate
Gabexate mesilate
Gabexate mesylate
Gabexate monomethanesulfonate
Gabexato mesilato [Spanish]
p-Hydroxybenzoic acid ethyl ester 6-guanidinohexanoate mesilate
39492-01-8
56974-61-9
[N'-[5-(4-ethoxycarbonylphenoxy)carbonylpentyl]carbamimidoyl]azanium; methanesulfonate
Registries:
PubChem CID 42080
PubChem ID 182710
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|